291 related articles for article (PubMed ID: 10448444)
1. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
[TBL] [Abstract][Full Text] [Related]
2. Combined antidepressants and CBT for panic disorder with agoraphobia.
Coupland NJ
J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
[No Abstract] [Full Text] [Related]
3. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
Oei TP; Llamas M; Evans L
Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
[TBL] [Abstract][Full Text] [Related]
4. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
Barlow DH; Gorman JM; Shear MK; Woods SW
JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
[TBL] [Abstract][Full Text] [Related]
5. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
[TBL] [Abstract][Full Text] [Related]
6. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
9. Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia.
Bischoff S; Wieder G; Einsle F; Petzold MB; Janßen C; Mumm JLM; Wittchen HU; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Jun; 101():34-41. PubMed ID: 29539585
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments.
van Balkom AJ; Bakker A; Spinhoven P; Blaauw BM; Smeenk S; Ruesink B
J Nerv Ment Dis; 1997 Aug; 185(8):510-6. PubMed ID: 9284865
[TBL] [Abstract][Full Text] [Related]
11. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia.
Cottraux J; Note ID; Cungi C; Légeron P; Heim F; Chneiweiss L; Bernard G; Bouvard M
Br J Psychiatry; 1995 Nov; 167(5):635-41. PubMed ID: 8564320
[TBL] [Abstract][Full Text] [Related]
12. [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
Boerner RJ
Psychiatr Prax; 1995 Jan; 22(1):30-2. PubMed ID: 7892341
[TBL] [Abstract][Full Text] [Related]
13. Implementing panic-focused psychodynamic psychotherapy into clinical practice.
Beutel ME; Scheurich V; Knebel A; Michal M; Wiltink J; Graf-Morgenstern M; Tschan R; Milrod B; Wellek S; Subic-Wrana C
Can J Psychiatry; 2013 Jun; 58(6):326-34. PubMed ID: 23768260
[TBL] [Abstract][Full Text] [Related]
14. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R
Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307
[TBL] [Abstract][Full Text] [Related]
15. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
16. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
[TBL] [Abstract][Full Text] [Related]
17. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.
Hendriks GJ; Keijsers GP; Kampman M; Oude Voshaar RC; Verbraak MJ; Broekman TG; Hoogduin CA
Acta Psychiatr Scand; 2010 Jul; 122(1):11-9. PubMed ID: 19958308
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the cost and the effectiveness of a psychotherapy for panic disorder with agoraphobia (PDA) versus a treatment combining pharmacotherapy and psychotherapy].
Marchand A; Germain V; Reinharz D; Mainguy N; Landry P
Sante Ment Que; 2004; 29(2):201-20. PubMed ID: 15928793
[TBL] [Abstract][Full Text] [Related]
20. [The role of psychotherapy in managing panic disorder].
Cottraux J
Encephale; 1996 Dec; 22 Spec No 5():54-60. PubMed ID: 9138948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
